Approximately 80% of patients with serogroup 1 Legionella pneumophila pneumonia excrete detectable levels of an antigen, presumably derived from the organism, in their urine (7) . Assays developed to detect this antigen appear to be highly specific, yielding positive results only in patients with legionellosis (7, 9, 13, 14) . To be optimally useful as diagnostic tools for physicians making therapeutic decisions, these assays must detect antigen early in the course of the illness. Furthermore, antigen excretion must end with, or soon after, symptomatic recovery from the illness if the assays are to be useful for detecting relapses or reinfections with legionella organisms. We therefore analyzed our experiences with urinary antigen detection over a 54-month period to determine whether antigen detection in Legionnaires disease is possible early in the illness and whether antigen excretion stops after successful treatment of the illness.
MATERIALS AND METHODS
Patient population. From the only corroborative laboratory evidence for Legionnaires disease; urine from 6 of these patients failed to demonstrate seroconversion by indirect fluorescent-antibody examination, and the other 7 had no convalescent specimen examined.
Thirty-one of the 100 specimens were analyzed as part of a prospective evaluation of diagnostic tests during an outbreak of Legionnaires disease (6, 8) . Fifty-four other specimens were submitted by physicians as part of their diagnostic evaluations of patients with pneumonias suspected to be Legionnaires disease. The remaining 15 specimens were collected for analysis from patients already known by other means to have Legionnaires disease. When possible, usually because of prolonged hospitalization, proximity to Indiana University Hospitals, frequent outpatient evaluations, or some combination of these conditions, urine specimens were collected until contact with the patient was broken through discharge or death or until antigen could no longer be detected.
Dates of onset of illness were determined by reviewing the medical records of the patients. For community-acquired infections, the date of onset of illness was determined from information recorded in the admitting patient history, and for nosocomial infections, the date of onset was determined by evaluation of daily temperature records and serial chest radiographs. For patients from other institutions information was obtained by telephone or letter from a physician involved in care of the patient.
Antigen detection. Urine specimens were examined for serogroup 1 L. pneumophila antigen by solid-phase radioimmunoassay or enzyme-linked immunoassay as previously described (8, 14) . The two methods produced comparable results (14) . RESULTS Dates of onset of symptoms could not be determined for 4 of the 100 patients; these 4 cause they were collected prospectively when the index of suspicion for Legionnaires disease was high, and they may therefore better represent the entire spectrum of disease severity than the remaining specimens. Serological followup on this subgroup of patients was also better than in the remaining patients, who tended to have convalescent serological evaluation only if a culture, direct fluorescent-antibody examination, or urinary antigen test was positive. Only the first specimen collected from each patient is represented in Table 2 ). The longest duration of antigen excretion was 326 days. Ten of the 23 patients excreted antigen for 42 days or longer. All these patients recovered from their Legionnaires disease and felt well despite continued antigen excretion; thus, persistent antigen excretion did not reflect persistent clinical infection. Fifty-nine other patients continued to excrete antigen when last tested, in five cases for longer than 40 days (Table 3) . Although most of the patients who excreted antigen for prolonged periods were receiving immunosuppressant medication, five who excreted antigen for more than 40 days (two from Table 2, three from Table 3 ) had no apparent immunological abnormalities. Thus, antigen excretion may end soon after treatment is begun in some patients but may persist for months in others.
DISCUSSION
To be optimally useful to physicians making therapeutic decisions, the immunoassays for L. pneumophila antigen must detect antigen early in the course of the illness. The data presented in Table 1 indicate that, if antigen is going to be detected at all, it can be detected as often during the first 3 days after symptoms begin as at later times. Thus, we conclude that the immunoassays should enable physicians to determine, early in the course of the illness and in time to initiate appropriate antibiotic therapy, that serogroup 1 Legionnaires disease is present.
Once present, however, antigen may continue to be excreted in detectable quantities in urine for prolonged periods of time despite appropriate treatment and apparent recovery from infection. Our initial experience suggested that antigen excretion is often short-lived (9). Since then, however, the URINARY ANTIGEN EXCRETION IN LEGIONNAIRES DISEASE 607 assays have been improved by the use of higher-titered antiserum (10) . As a result, those patients who apparently stopped excreting antigen after 3 to 14 days of erythromycin therapy (9) have subsequently been shown to be excreting antigen in all urine specimens collected. That infected humans may excrete microbial antigens for prolonged periods is not a new observation. Using a relatively insensitive precipitation technique, Dochez and Avery reported in 1917 that three patients who had recovered from pneumococcal pneumonia still excreted pneumococcal polysaccharide at 40, 42, and 58 days after onset of their illnesses (3). Their observations were confirmed by others (2, 12) . More recently, O'Reilly et al. detected circulating capsular polysaccharide, complexed with immunoglobulin, 145 days after hospitalization in the serum of a patient who had recovered from type b Haemophilus influenzae meningitis (11) . Prolonged unnary excretion of polysaccharides after infections with Cryptococcus neoformans (4) and Salmonella typhi (1) has also been documented. After injection into mice, pneumococcal polysaccharide is present in many tissues 8 to 12 months later (5, 15) . Thus, some microbial polysaccharides appear to be degraded very slowly, or not at all, by mammalian tissues, probably accounting for their prolonged appearance in urine. Although the exact nature of the L. pneumophila urinary antigen is not known, it withstands boiling for 30 min and treatment with pepsin, trypsin, pronase, and proteinase K (9; Kohler, unpublished observations) suggesting that it is a polysaccharide.
The biological implications of the prolonged urinary excretion of L. pneumophila antigen are unclear. The involved patients were not carefully studied but appeared to have recovered from their illnesses with no ill effects. However, the observation that antigen excretion may be prolonged means that urinary antigen detection cannot be relied upon to provide useful diagnostic information in patients with recurrent pneumonias in the months following recovery from L. pneumophila pneumonia.
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